Contraceptive use among sexually active women living with HIV in western Ethiopia.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
10
2019
accepted:
22
07
2020
entrez:
8
8
2020
pubmed:
8
8
2020
medline:
7
10
2020
Statut:
epublish
Résumé
Contraception can help to meet family planning goals for women living with HIV (WLHIV) as well as to support the prevention of mother to child transmission of HIV (PMTCT). However, there is little research into the contraceptive practice among sexually active WLHIV in Ethiopia. Therefore, we aimed to examine contraceptive practice among sexually active WLHIV in western Ethiopia and identify the factors that influenced such practice using the Health Belief Model (HBM). A facility-based cross-sectional survey of 360 sexually active WLHIV was conducted from 19th March to 22nd June 2018 in western Ethiopia. The eligible participants were WLHIV aged between 18 and 49 years who reported being fecund and sexually active within the previous six months but were not pregnant and not wanting to have another child within two years. Modified Poisson regression analyses were conducted to identify factors that influenced contraceptive practice among sexually active WLHIV in western Ethiopia. Among sexually active WLHIV (n = 360), 75% used contraception with 25% having unmet needs. Of the contraceptive users, 44.8% used injectables, 37.4% used condoms and 28.5% used implants. Among 152 recorded births in the last five years, 17.8% were reported as mistimed and 25.7% as unwanted. Compared to WLHIV having no child after HIV diagnosis, having two or more children after HIV diagnosis (Adjusted Prevalence Ratio [APR] = 1.31; 95%CI 1.09-1.58) was associated with increased risk of contraceptive practice. However, sexually active unmarried WLHIV (APR = 0.69; 95%CI 0.50-0.95) were less likely to use any contraception compared to their sexually active married counterparts. Importantly, high perceived susceptibility (APR = 1.49; 95%CI 1.20-1.86) and medium perceived susceptibility (APR = 1.55; 95%CI 1.28-1.87) towards unintended pregnancy were associated with higher risk of contraceptive use than WLHIV with low perceived susceptibility. Although contraceptive use amongst sexually active WLHIV was found to be high, our findings highlight the need for strengthening family planning services given the high rate of unintended pregnancies, the high rate of unmet needs for contraception, as well as the lower efficacy with some of the methods. Our findings also suggest that the HBM would be a valuable framework for healthcare providers, programme planners and policymakers to develop guidelines and policies for contraceptive counselling and choices.
Identifiants
pubmed: 32760140
doi: 10.1371/journal.pone.0237212
pii: PONE-D-19-30290
pmc: PMC7410321
doi:
Substances chimiques
Contraceptive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0237212Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ethiop Med J. 2008 Oct;46(4):335-47
pubmed: 19271398
Public Health. 2019 Mar;168:128-136
pubmed: 30769244
BMC Public Health. 2014 Jun 06;14:566
pubmed: 24902478
AIDS Behav. 2019 Jun;23(6):1431-1451
pubmed: 30467712
Occup Environ Med. 2008 Jul;65(7):481, 501-6
pubmed: 18562687
BMC Public Health. 2017 Jul 5;17(1):626
pubmed: 28679389
PLoS One. 2019 Jan 25;14(1):e0211298
pubmed: 30682131
Contraception. 2011 May;83(5):453-8
pubmed: 21477689
BMC Womens Health. 2018 Apr 27;18(1):60
pubmed: 29699548
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
ISRN AIDS. 2013 Sep 25;2013:319724
pubmed: 24224116
Asia Pac J Public Health. 2012 Jan;24(1):151-60
pubmed: 20829275
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Lancet. 2011 Jul 16;378(9787):269-78
pubmed: 21763938
PLoS One. 2017 May 1;12(5):e0176256
pubmed: 28459866
Obstet Gynecol. 2011 Aug;118(2 Pt 1):323-33
pubmed: 21775849
PLoS One. 2010 Nov 05;5(11):e13868
pubmed: 21079770
Cochrane Database Syst Rev. 2016 Aug 09;(8):CD010243
pubmed: 27505053
J Midwifery Womens Health. 2012 Jan-Feb;57(1):74-81
pubmed: 22251916
PLoS One. 2017 Nov 13;12(11):e0187311
pubmed: 29131860
Sex Transm Dis. 2006 Jun;33(6):350-6
pubmed: 16505747
Int J Gynaecol Obstet. 2017 May;137(2):174-179
pubmed: 28170078
AIDS. 2009 Nov;23 Suppl 1:S123-30
pubmed: 20081384
Perspect Sex Reprod Health. 2018 Jun;50(2):67-73
pubmed: 29603597
Lancet. 2016 Jan 2;387(10013):53-60
pubmed: 26364263
AIDS Behav. 2018 Dec;22(12):3971-3980
pubmed: 30073635
PLoS One. 2018 May 22;13(5):e0197366
pubmed: 29787587
Int J Reprod Med. 2019 Aug 26;2019:3276780
pubmed: 31534951
Lancet. 2018 Mar 3;391(10123):870-882
pubmed: 29217374
J Fam Plann Reprod Health Care. 2012 Jan;38(1):23-9
pubmed: 21795262
Emerg Themes Epidemiol. 2013 Dec 13;10(1):14
pubmed: 24330636
Lancet. 2016 Oct 8;388(10053):1813-1850
pubmed: 27665228
Am J Public Health. 2008 Oct;98(10):1746-50
pubmed: 18703432
PLoS One. 2014 Aug 21;9(8):e105320
pubmed: 25144229
BMJ Open. 2012 Nov 20;2(6):
pubmed: 23169875
Am J Obstet Gynecol. 2016 Jul;215(1):78.e1-9
pubmed: 26827879
Trop Med Int Health. 2012 Aug;17(8):e84-93
pubmed: 22943383
BMC Health Serv Res. 2017 Mar 14;17(1):194
pubmed: 28288616
Evid Based Nurs. 2015 Jul;18(3):66-7
pubmed: 25979629
Health Educ Q. 1985 Summer;12(2):185-210
pubmed: 3997538
Cochrane Database Syst Rev. 2013 Oct 26;(10):CD004317
pubmed: 24163097
AIDS Behav. 2009 Jun;13 Suppl 1:38-46
pubmed: 19343492
Sex Transm Infect. 2011 Apr;87(3):183-90
pubmed: 21330572
BMC Res Notes. 2018 Sep 17;11(1):671
pubmed: 30223872
Clin Obstet Gynecol. 2014 Dec;57(4):659-73
pubmed: 25264697
Int Perspect Sex Reprod Health. 2014 Mar;40(1):28-38
pubmed: 24733059
Soc Sci Med. 2007 Jul;65(2):274-83
pubmed: 17451852